Cardiovascular Systems Inc. (NASDAQ:CSII) shares fell to a low of $41.88 before closing at $43.20. Intraday shares traded counted 0.2 million, which was 27.82% higher than its 30-day average trading volume of 281.05K. CSII’s previous close was $43.48 while the outstanding shares total 38.81M. The firm has a beta of 0.91. The stock’s Relative Strength Index (RSI) is 47.52, with weekly volatility at 3.69% and ATR at 1.91. The CSII stock’s 52-week price range has touched low of $26.00 and a $48.28 high. The stock traded lower over the last trading session, losing -0.64% on 02/11/21.
Investors have identified the Medical Devices company Cardiovascular Systems Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $1.71 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cardiovascular Systems Inc. (CSII) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 293.08 million total, with 48.09 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.13 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CSII sounds very interesting.
Is the stock of CSII attractive?
In related news, Chief Compliance Officer, Sedo Sandra sold 2,914 shares of the company’s stock in a transaction that recorded on Aug 24. The sale was performed at an average price of 31.94, for a total value of 93,067. As the sale deal closes, the General Counsel & Corp. Sec., Rosenstein Alexander now sold 4,692 shares of the company’s stock, valued at 149,853. Also, Chief Compliance Officer, Sedo Sandra sold 440 shares of the company’s stock in a deal that was recorded on Aug 18. The shares were price at an average price of 32.89 per share, with a total market value of 14,471. Following this completion of acquisition, the Director, Paulsen Erik now holds 200 shares of the company’s stock, valued at 6,570. In the last 6 months, insiders have changed their ownership in shares of company stock by 2.80%.
5 out of 9 analysts covering the stock have rated it a Buy, while 3 have maintained a Hold recommendation on Cardiovascular Systems Inc.. 0 analysts has assigned a Sell rating on the CSII stock. The 12-month mean consensus price target for the company’s shares has been set at $47.00.